CROSSROADS STRATEGIES, LLC for GENENTECH, INC.
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
Issues related to the United States-Mexico-Canada Agreement (USMCA). Issues related to biopharmaceutical IP. Issues related to prescription drug supply chains; H.R.6482/S.3537/S.3635, Protecting Our Pharmaceutical Supply Chain from China Act of 2020; H.R.6431, Made in America Emergency Preparedness Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATHERINE DAPPER | — |
| JASON GLEASON | — |
| JOHN GREEN | — |
| STEWART HALL | — |
| SHAY MICHAEL HANCOCK | — |
| MATHEW LAPINSKI | — |
| HUNTER MOORHEAD | — |
| JASON BENJAMIN VAN PELT | — |
| TODD MATTHEW WEISS | — |
Taxation/Internal Revenue Code TAX
Implementation of Tax Cuts and Jobs Act (P.L.115-97).
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATHERINE DAPPER | — |
| JASON GLEASON | — |
| JOHN GREEN | — |
| STEWART HALL | — |
| SHAY MICHAEL HANCOCK | — |
| MATHEW LAPINSKI | — |
| HUNTER MOORHEAD | — |
| JASON BENJAMIN VAN PELT | — |
| TODD MATTHEW WEISS | — |
Health Issues HCR
Issues related to health care, the Food and Drug Administration (FDA), 340B Program, influenza, drug pricing, importation of biopharmaceuticals, international pharmaceutical supply chain, and education around COVID-19 therapies. Implementation of Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 (P.L.116-22). H.R.6395/S.4049, National Defense Authorization Act for Fiscal Year 2021. Executive Order on Access to Affordable Life-saving Medications (E.O. 13937). Executive Order on Increasing Drug Importation to Lower Prices for American Patients (E.O. 13938). Executive Order on Lowering Prices for Patients by Eliminating Kickbacks to Middlemen (E.O. 13939). Executive Orders on Lowering Drug Prices by Putting America First (E.O. 13947, E.O. 13948). Executive Order on Combating Public Health Emergencies and Strengthening National Security by Ensuring Essential Medicines, Medical Countermeasures, and Critical Inputs Are Made in the United States (E.O. 13944). Executive Order on An America-First Healthcare Plan (E.O. 13951).
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATHERINE DAPPER | — |
| JASON GLEASON | — |
| JOHN GREEN | — |
| STEWART HALL | — |
| SHAY MICHAEL HANCOCK | — |
| MATHEW LAPINSKI | — |
| HUNTER MOORHEAD | — |
| JASON BENJAMIN VAN PELT | — |
| TODD MATTHEW WEISS | — |
Medicare/Medicaid MMM
General issues related to Medicare and Medicaid, such as: Part D Medicare Program, Medicare Part B reimbursement, and drug pricing. Proposed Part B IPI Demonstration Project. H.R.3, Lower Drug Costs Now Act of 2019. S.2543, Prescription Drug Pricing Reduction Act of 2019. H.R.19, Lower Costs, More Cures Act of 2019. S.1895, Lower Health Care Costs Act of 2019. H.R.1425, Patient Protection and Affordable Care Enhancement Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATHERINE DAPPER | — |
| JASON GLEASON | — |
| JOHN GREEN | — |
| STEWART HALL | — |
| SHAY MICHAEL HANCOCK | — |
| MATHEW LAPINSKI | — |
| HUNTER MOORHEAD | — |
| JASON BENJAMIN VAN PELT | — |
| TODD MATTHEW WEISS | — |
Copyright/Patent/Trademark CPT
Biopharmaceutical innovation and patent policy issues. Trademark legislative proposals. Bayh-Dole march-in rights policy issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATHERINE DAPPER | — |
| JASON GLEASON | — |
| JOHN GREEN | — |
| STEWART HALL | — |
| SHAY MICHAEL HANCOCK | — |
| MATHEW LAPINSKI | — |
| HUNTER MOORHEAD | — |
| JASON BENJAMIN VAN PELT | — |
| TODD MATTHEW WEISS | — |
Budget/Appropriations BUD
Issues related to supplemental appropriations and federal health programs; FY2021 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.7614), FY2021 Consolidated Appropriations Act (H.R.7617), Reimbursement and vial size issues; H.R.6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (P.L.116-123); H.R.748, CARES Act (P.L.116-136); H.R.6800, The Heroes Act; The HEALS Act; H.R.8337, Continuing Appropriations Act, 2021 and Other Extensions Act; H.R.133, Making consolidated appropriations for the fiscal year ending September 30, 2021, providing coronavirus emergency response and relief, and for other purposes (P.L.116-260).
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATHERINE DAPPER | — |
| JASON GLEASON | — |
| JOHN GREEN | — |
| STEWART HALL | — |
| SHAY MICHAEL HANCOCK | — |
| MATHEW LAPINSKI | — |
| HUNTER MOORHEAD | — |
| JASON BENJAMIN VAN PELT | — |
| TODD MATTHEW WEISS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.